Submit your Defective Drugs claim details for a free, no obligation case review.
Get Started:
drug_recall nuvaringNuvaRing may increase the risk of potentially deadly blood clots and other deadly NuvaRing side effects. In 2008, a spokesperson for the consumer advocacy group Public Citizen said the agency was looking into the product and would likely consider a petition to ban it.
Twofold Risk of Blood Clots
The Food and Drug Administration approved NuvaRing in 2001 and the following year, the vaginal contraceptive became widely available. Used to prevent pregnancy, NuvaRing is a flexible ring inserted into the vagina where it remains for three weeks. During that time, it releases synthetic estrogen and progestin. Etonogestrel, the progestin in NuvaRing, is a form of desogestrol—a hormone in newer oral contraceptives that has been linked to a twofold risk of blood clots.
In February 2007, Public Citizen petitioned the FDA, seeking to ban newer oral contraceptives containing desogestrol because of the increased clotting risk.
Blood Clot Lawsuit
In March 2008, the family of a 32-year-old woman who developed a deadly blood clot after using NuvaRing filed a lawsuit against the contraceptive’s maker. The woman had been using the vaginal contraceptive for about six months when she suffered the blood clot. The lawsuit claimed that the maker of NuvaRing failed to provide adequate warnings regarding the risk of potentially fatal clotting.
Blood Clot Symptoms
Symptoms of a blood clot may include:
A blood clot requires immediate medical attention. If you are using NuvaRing and experiencing any of the symptoms listed above, contact a healthcare provider immediately.
Injured by NuvaRing?
If you or someone you love has suffered a blood clot while using NuvaRing, you may be eligible to file a lawsuit to recover compensation for your losses. Contact us today to arrange a free, private consultation with an experienced attorney who can inform you of your rights and legal options.